Ansar Karimian
Overview
Explore the profile of Ansar Karimian including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
2435
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tod N, Vogelauer M, Cheng C, Karimian A, Schmollinger S, Camacho D, et al.
J Biol Chem
. 2024 Apr;
300(6):107314.
PMID: 38657861
The copper reductase activity of histone H3 suggests undiscovered characteristics within the protein. Here, we investigated the function of leucine 126 (H3L126), which occupies an axial position relative to the...
2.
Karimian A, Vogelauer M, Kurdistani S
PLoS Biol
. 2023 Oct;
21(10):e3002371.
PMID: 37889915
Perez and Sarkies uncover histones as methyl group repositories in normal and cancer human cells, shedding light on an intriguing function of histone methylation in optimizing the cellular methylation potential...
3.
Rahimipour Anaraki S, Farzami P, Hosseini Nasab S, Kousari A, Fazlollahpour Naghibi A, Shariat Zadeh M, et al.
Naunyn Schmiedebergs Arch Pharmacol
. 2023 Oct;
397(5):2531-2549.
PMID: 37878043
The control of biological cell death is essential for the body's appropriate growth. The resistance of cells to the apoptotic process presents a new difficulty in the treatment of cancer....
4.
Vogelauer M, Cheng C, Karimian A, Iranpour H, Kurdistani S
bioRxiv
. 2023 Sep;
PMID: 37745536
The histone H3-H4 tetramer is a copper reductase enzyme, facilitating the production of cuprous (Cu) ions for distribution to copper-dependent enzymes. It was, however, unknown if this enzymatic activity occurred...
5.
Karimian A, Majidinia M, Moliani A, Alemi F, Asemi Z, Yousefi B, et al.
Pathol Res Pract
. 2022 Nov;
240:154143.
PMID: 36347210
Background: The recent decade has witnessed the increasing potential of various flavonoids such as quercetin and thymoquinone in inhibiting cancer cells proliferation and growth and their therapeutic effects in various...
6.
Malakoti F, Targhazeh N, Abadifard E, Zarezadeh R, Samemaleki S, Asemi Z, et al.
Cancer Cell Int
. 2022 May;
22(1):176.
PMID: 35501851
Malignant mesothelioma (MMe) is an aggressive neoplasm that occurs through the transformation of mesothelial cells. Asbestos exposure is the main risk factor for MMe carcinogenesis. Other important etiologies for MMe...
7.
Tehrani S, Zaboli E, Sadeghi F, Khafri S, Karimian A, Rafie M, et al.
Biomedicine (Taipei)
. 2022 Feb;
11(2):30-39.
PMID: 35223402
Background: Breast cancer (BC) is known as the most prevalent type of cancer among women. Trastuzumab, as an anticancer drug, has been used broadly in human epidermal growth factor receptor...
8.
Karimian A, Yousefi B, Sadeghi F, Feizi F, Najafzadehvarzi H, Parsian H
Chem Biol Interact
. 2021 Nov;
351:109731.
PMID: 34728188
We designed amine-functionalized nanocrystalline cellulose grafted folic acid/magnetic nanoparticles (AF-NCC/FeO NPs) against folate receptors for targeted delivery of doxorubicin (DOX). Toxicity is a major side effect of DOX, damaging vital...
9.
Mohammadi E, Sadoughi F, Younesi S, Karimian A, Asemi Z, Farsad-Akhtar N, et al.
DNA Repair (Amst)
. 2021 Apr;
103:103115.
PMID: 33915415
This review summarizes and addresses non-coding RNAs (rRNA, tRNA, Vault and Y RNA, snRNA, and miRNA) cytoplasmic decay pathways, the molecules, enzymes, and modifications such as uridylation, which play vital...
10.
Mirza-Aghazadeh-Attari M, Recio M, Darband S, Kaviani M, Safa A, Mihanfar A, et al.
DNA Repair (Amst)
. 2021 Jan;
98:103032.
PMID: 33494010
Breast cancer is the most common and significant cancers in females regarding the loss of life quality. Similar to other cancers, one of the etiologic factors in breast cancer is...